Gemvaxlink Co. Ltd (064800) - Net Assets

Latest as of June 2026: ₩166.26 Billion KRW ≈ $112.67 Million USD

Based on the latest financial reports, Gemvaxlink Co. Ltd (064800) has net assets worth ₩166.26 Billion KRW (≈ $112.67 Million USD) as of June 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩205.70 Billion ≈ $139.40 Million USD) and total liabilities (₩39.43 Billion ≈ $26.72 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check 064800 strategic asset allocation to assess the company's strategic physical and investment asset allocation.

Key Net Assets Metrics

Metric	Value
Current Net Assets	₩166.26 Billion
% of Total Assets	80.83%
Annual Growth Rate	14.03%
5-Year Change	14.15%
10-Year Change	458.69%
Growth Volatility	41.6

Gemvaxlink Co. Ltd - Net Assets Trend (2011–2025)

This chart illustrates how Gemvaxlink Co. Ltd's net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see Gemvaxlink Co. Ltd (064800) market capitalisation.

Annual Net Assets for Gemvaxlink Co. Ltd (2011–2025)

The table below shows the annual net assets of Gemvaxlink Co. Ltd from 2011 to 2025. Also explore 064800 net assets growth trend to track the company's year-over-year net asset growth rate.

Year	Net Assets	Change
2025-12-31	₩216.10 Billion ≈ $146.45 Million	+9.00%
2024-12-31	₩198.25 Billion ≈ $134.35 Million	+33.74%
2023-12-31	₩148.23 Billion ≈ $100.46 Million	-12.52%
2022-12-31	₩169.44 Billion ≈ $114.83 Million	-10.50%
2021-12-31	₩189.31 Billion ≈ $128.29 Million	+27.05%
2020-12-31	₩149.00 Billion ≈ $100.98 Million	+12.34%
2019-12-31	₩132.64 Billion ≈ $89.89 Million	+19.29%
2018-12-31	₩111.18 Billion ≈ $75.35 Million	+13.40%
2017-12-31	₩98.04 Billion ≈ $66.44 Million	+153.47%
2016-12-31	₩38.68 Billion ≈ $26.21 Million	+49.92%
2015-12-31	₩25.80 Billion ≈ $17.48 Million	+5.07%
2014-12-31	₩24.56 Billion ≈ $16.64 Million	-16.58%
2013-12-31	₩29.44 Billion ≈ $19.95 Million	-9.72%
2012-12-31	₩32.60 Billion ≈ $22.10 Million	-5.16%
2011-12-31	₩34.38 Billion ≈ $23.30 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Gemvaxlink Co. Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have decreased by 1932924791000.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2025)

Component	Amount	Percentage
Other Components	₩235.43 Billion	108.94%
Total Equity	₩216.10 Billion	100.00%

Gemvaxlink Co. Ltd Competitors by Market Cap

The table below lists competitors of Gemvaxlink Co. Ltd ranked by their market capitalization.

Company	Market Cap
BYC Co Ltd KO:001465	$37.94 Million
Taekyung Chem KO:006890	$37.94 Million
Müller - Die lila Logistik AG XETRA:MLL	$37.95 Million
CervoMed Inc. NASDAQ:CRVO	$37.95 Million
Widodo Makmur Unggas Tbk PT JK:WMUU	$37.92 Million
Vivoryon Therapeutics NV AS:VVY	$37.91 Million
Mirae Asset Global REIT Co. Ltd. KO:396690	$37.90 Million
Aurumin Ltd AU:AUN	$37.88 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Gemvaxlink Co. Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 198,249,734,780 to 216,097,181,430, a change of 17,847,446,650 (9.0%).
Net income of 15,848,001,420 contributed positively to equity growth.
New share issuances of 478,484,960 increased equity.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	₩15.85 Billion	+7.33%
Share Issuances	₩478.48 Million	+0.22%
Other Changes	₩1.52 Billion	+0.7%
Total Change	₩-	9.00%

Book Value vs Market Value Analysis

This analysis compares Gemvaxlink Co. Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 0.26x
The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
The price-to-book ratio has decreased from 1.98x to 0.26x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2016-12-31	₩1118.57	₩2220.00	x
2017-12-31	₩1887.77	₩2220.00	x
2018-12-31	₩1885.61	₩2220.00	x
2019-12-31	₩1839.30	₩2220.00	x
2020-12-31	₩1896.53	₩2220.00	x
2021-12-31	₩2276.00	₩2220.00	x
2022-12-31	₩2023.27	₩2220.00	x
2023-12-31	₩1913.36	₩2220.00	x
2024-12-31	₩1572.80	₩2220.00	x
2025-12-31	₩8571.94	₩2220.00	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Gemvaxlink Co. Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 7.33%
The company has moderate efficiency in generating returns from equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 35.30%
• Asset Turnover: 0.16x
• Equity Multiplier: 1.33x
Recent ROE (7.33%) is above the historical average (-1.06%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2011	4.99%	3.62%	0.98x	1.41x	₩-1.61 Billion
2014	-5.92%	-7.11%	0.67x	1.24x	₩-3.94 Billion
2015	4.09%	6.62%	0.40x	1.54x	₩-1.52 Billion
2016	0.57%	0.66%	0.45x	1.90x	₩-3.65 Billion
2017	2.92%	1.48%	0.51x	3.90x	₩-6.94 Billion
2018	-17.21%	-36.17%	0.28x	1.70x	₩-30.25 Billion
2019	2.54%	3.54%	0.51x	1.42x	₩-9.90 Billion
2020	6.51%	10.39%	0.47x	1.35x	₩-5.20 Billion
2021	18.25%	31.53%	0.46x	1.26x	₩15.62 Billion
2022	-11.42%	-20.25%	0.46x	1.21x	₩-36.29 Billion
2023	-7.11%	-14.74%	0.36x	1.33x	₩-25.36 Billion
2024	-19.37%	-62.63%	0.25x	1.24x	₩-58.22 Billion
2025	7.33%	35.30%	0.16x	1.33x	₩-5.76 Billion

Industry Comparison

This section compares Gemvaxlink Co. Ltd's net assets metrics with peer companies in the Software - Application industry.

Industry Context

Industry: Software - Application
Average net assets among peers: $49,643,766,878
Average return on equity (ROE) among peers: -0.37%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Gemvaxlink Co. Ltd (064800)	₩166.26 Billion	4.99%	0.24x	$37.93 Million
Douzone Bizon Co Ltd (012510)	$153.29 Billion	18.37%	0.54x	$2.28 Billion
NuriFlex Co.Ltd (040160)	$49.16 Billion	-11.88%	1.85x	$49.69 Million
Raonsecure Co. Ltd (042510)	$5.18 Billion	0.00%	3.23x	$86.48 Million
Osangjaiel Co. Ltd (053980)	$109.09 Billion	9.51%	0.35x	$30.79 Million
Mobileleader Co.Ltd (100030)	$29.77 Billion	0.25%	0.14x	$35.66 Million
Selvas Ai Inc. (108860)	$29.18 Billion	0.00%	0.19x	$157.95 Million
RSUPPORT Co. Ltd (131370)	$46.45 Billion	-0.09%	0.11x	$53.14 Million
KineMaster Corporation (139670)	$12.36 Billion	-25.44%	0.13x	$19.61 Million
Bflysoft Co. Ltd. (148780)	$12.32 Billion	5.95%	0.34x	$82.47 Million

About Gemvaxlink Co. Ltd

KQ:064800 Korea Software - Application

Market Cap

$37.93 Million

₩55.97 Billion KRW

Market Cap Rank

#23018 Global

#1529 in Korea

Share Price

₩2220.00

Change (1 day)

-7.11%

52-Week Range

₩603.00 - ₩3600.00

All Time High

₩6877.62